Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Thank you for your interest in Astronomer
Astronomer’s recent ad, featuring Gwyneth Paltrow, pokes fun at the viral event that thrust the company into the public spotlight.
Playful Rewards
This app may play games with your money.
CATrends: Deceptive Influencer Marketing
It’s a hot sponcon summer.
Enterprise Rent-A-Car
What’s this reservation good for?
Prevagen May Have Memory Problems
TINA.org continues to support FTC, New York in federal court.